Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy

作者：Martin Hosking, Soheila Shirinbak, Kyla Omilusik, Shilpi Chandra, Mika K. Kaneko, Ángela Gentile, Susumu Yamamoto, Bishwas Shrestha, Joy Grant, Megan Boyett, Demetrio Cardenas, Hannah Keegan, Samad Ibitokou, C. Pavon, Takahiro Mizoguchi, Tatsuya Ihara, Daisuke Nakayama, Ramzey Abujarour, Tom T. Lee, Raedun Clarke, Jode Goodridge, Eigen Peralta, Tatsuo Maeda, Junichi Takagi, Takao Arimori, Yukinari Kato, Bahram Valamehr · 发表于：Cell stem cell · 年份：2025 · DOI：10.1016/j.stem.2025.05.007 · 被引用次数：22 · 研究领域：CAR-T cell therapy research、Viral Infectious Diseases and Gene Expression in Insects、Monoclonal and Polyclonal Antibodies Research